Unitedhealth (UNH) Cash & Equivalents (2009 - 2026)

Unitedhealth (UNH) has reported Cash & Equivalents for 18 consecutive years, with $28.0 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents fell 8.84% year-over-year to $28.0 billion; the TTM figure through Mar 2026 stood at $28.0 billion (down 8.84% YoY), while the FY2025 annual figure was $24.4 billion, down 3.74% from the prior year.
• Cash & Equivalents grew to $28.0 billion in Q1 2026 per UNH's latest filing, from $24.4 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $41.9 billion in Q1 2023 and bottomed at $266.0 million in Q4 2022.
• Historically, Cash & Equivalents has averaged $27.3 billion across 5 years, with a median of $28.0 billion in 2026.
• Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 87.72% — and 2024, when it soared 3161.86%.
• Unitedhealth's Cash & Equivalents stood at $266.0 million in 2022, then jumped by 191.73% to $776.0 million in 2023, then surged by 3161.86% to $25.3 billion in 2024, then retreated by 3.74% to $24.4 billion in 2025, then rose by 14.92% to $28.0 billion in 2026.
• Business Quant data shows UNH's Cash & Equivalents at $28.0 billion in Q1 2026, $24.4 billion in Q4 2025, and $27.2 billion in Q3 2025.